A sample text widget

Etiam pulvinar consectetur dolor sed malesuada. Ut convallis euismod dolor nec pretium. Nunc ut tristique massa.

Nam sodales mi vitae dolor ullamcorper et vulputate enim accumsan. Morbi orci magna, tincidunt vitae molestie nec, molestie at mi. Nulla nulla lorem, suscipit in posuere in, interdum non magna.

Crucell And GSK Agree on Malaria Vaccine Deal

Dutch firm, Crucell agreed with Britain’s to jointly develop a malaria vaccine candidate.

The deal is an extension to an earlier programme agreed in October 2003 between Crucell, and the Walter Reed Army Institute of Research to evaluate Crucell’s malaria vaccine candidate in pre-clinical studies.

Crucell said pre-clinical data indicated greatly enhanced immune responses against the malaria parasite when Crucell’s Adenovirus technology and GSK’s RTS,S/AS technology are used in combination, versus either component alone.

The companies aim to start human clinical studies and seek third-party funding to advance the programme into a phase I/IIa clinical challenge trial in the United States.

VN:F [1.9.22_1171]
Rating: 0.0/10 (0 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>